Comparative effect of chemoprevention in malaria infection during pregnancy: A network meta‐analysis
British Journal of Clinical Pharmacology · 2025
DOI: 10.1002/bcp.70396 ↗Kurz gefasst
Metaanalyse in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Cho Naing und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Dentistry, James Cook University, Queensland, Australia. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Pregnancy Complications, Parasitic. Die Arbeit nennt 62 Literaturangaben.
Abstract (Originalsprache)
Background
This study aimed to synthesize evidence on the relative effectiveness of antimalarial drugs used as chemoprevention of malaria in pregnancy (MIP) using network meta‐analysis (NMA).
Methods
Searches for eligible studies were made in multiple electronic databases, including PubMed. Randomized controlled trials (RCTs) that studied chemoprevention as intermittent preventive treatment of malaria during pregnancy (IPTp) compared to placebo or to another active antimalarial drug were included. A pair‐wise as well as an NMA were performed for each comparison. The certainty of evidence was rated with GRADE.
Results
We included 22 RCTs (N = 14 705). Eight studies were rated as high risk of bias. The common comparator for this NMA was placebo or IPTp with dihydroartemisinin ‐ piperaquine (DP). There is moderate certainty evidence that monthly single‐dose IPTp‐ sulphadoxine / pyrimethamine (IPTp‐SP) resulted in a greater reduction in maternal parasitaemia and anaemia compared to the placebo. However, there is low‐certainty evidence of fewer incidences of low birth weight with IPTp‐SP than with the combined DP and azithromycin .
Conclusion
The findings suggest that there is moderate certainty of evidence of the effect of IPTp‐SP monthly single dose on maternal parasitaemia and anaemia. Future research should include a head‐to‐head comparison with adequate samples and evaluate the effectiveness, safety, operational feasibility and cost‐effectiveness of IPTp for SP, DP, azithromycin and other potential antimalarials as either monotherapy or combination therapy. Information from endemic regions outside Africa, such as Asia and Latin America, is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine and Dentistry, James Cook University, Queensland, Australia.
- Department of Medicine, Newcastle University Medicine Malaysia, Johor, Malaysia.
- IMU University, Kuala Lumpur, Malaysia.
- College of Health and Science, University of Lincoln, UK.
ORCID-Profile: Cho Naing, Han Ni, Norah Htet Htet, Htar Htar Aung, Yaashini Anamalai, Syed Imran Ahmed, Maxine A Whittaker
Zitieren
APA
Naing, C., Ni, H., Htet, N. H., Aung, H. H., Anamalai, Y., Ahmed, S. I., & Whittaker, M. A. (2025). Comparative effect of chemoprevention in malaria infection during pregnancy: A network meta‐analysis. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70396
Vancouver
Naing C, Ni H, Htet NH, Aung HH, Anamalai Y, Ahmed SI, et al. Comparative effect of chemoprevention in malaria infection during pregnancy: A network meta‐analysis. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70396
BibTeX
@article{Naing2025,
author = {Naing, Cho and Ni, Han and Htet, Norah Htet and Aung, Htar Htar and Anamalai, Yaashini and Ahmed, Syed Imran and Whittaker, Maxine A},
title = {Comparative effect of chemoprevention in malaria infection during pregnancy: A network meta‐analysis},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/bcp.70396}
}
EUVIMED